Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era

Patients and physicians may defer unrelated donor hematopoietic cell transplantation (HCT) as curative therapy due to mortality risk associated with the procedure. Therefore, it is important for physicians to know the current outcomes data when counseling potential candidates. To provide this inform...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biol Blood Marrow Transplant
Asıl Yazarlar: Majhail, Navneet S, Chitphakdithai, Pintip, Logan, Brent, King, Roberta, Devine, Steven, Rossmann, Susan N, Hale, Gregory, Hartzman, Robert J, Karanes, Chatchada, Laport, Ginna G, Nemecek, Eneida, Snyder, Edward L, Switzer, Galen E, Miller, John, Navarro, Willis, Confer, Dennis L, Levine, John E
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4272902/
https://ncbi.nlm.nih.gov/pubmed/25445638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.10.001
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller